RxDoctor Payments Data

Hira Bakshi

Physician Assistant · Concord, NHNPI 1134757743

Payments from drug & device makers

$710in general payments, 2019–2025

Across 26 payments — averaging $27.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$184
  • Alnylam Pharmaceuticals Inc.$125
  • Bayer$104
  • Amgen$79
  • Merck$54
  • Pfizer$47
  • plus $117 from 6 others

What the payments were for

  • Food & beverage$710100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$710 in reported general payments places this provider in the 85th percentile of 782 physician assistant providers in New Hampshire.

See all physician assistant providers in New Hampshire

Medicare billing

Part B allowed, 2024
$43,897
Medicare patients
372
Services billed
634

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban256$246,103
XareltoRivaroxaban160$187,384
EntrestoSacubitril/Valsartan55$57,260
JardianceEmpagliflozin31$48,951
BrilintaTicagrelor35$15,025
Praluent PenAlirocumab21$10,874
Metoprolol Succinate527$6,353
Ezetimibe129$2,620
Diltiazem 24hr Er (Cd)Diltiazem Hcl86$2,428
Rosuvastatin Calcium196$2,377
Atorvastatin Calcium307$2,341
Ranolazine ErRanolazine32$1,546
Midodrine Hcl14$1,279
Potassium Chloride65$1,268
Losartan Potassium142$1,209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$47$246,103256 claims
Johnson & JohnsonXarelto$21$187,384160 claims
NovartisEntresto$31$57,26055 claims
Boehringer IngelheimJardiance$13$48,95131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 782 physician assistant providers in New Hampshire.

Other physician assistant in Concord

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →